/Investor DB

Privilège Ventures — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

Adipossadiposs.cominSeed · Jan 2022 · $2M

Adiposs develops ImageBAT, a contrast agent for medical imaging of brown fat that can identify patients at increased cancer risk and with higher treatment failure risk.

BiotechDigital HealthMedical Devices

Duc Tran(Chief Development Officer)

Co-investorsKickfund

SMEETZ - Newsmeetz.comin𝕏Series A · May 2022 · $4M

Smeetz builds AI-powered software for the attractions industry, offering tools such as dynamic pricing to optimise operations, capacity, and guest experiences.

AI & Machine LearningFintechRetail TechSaaSTravel & Hospitality

Alexandre Martin(Founder)in

Co-investorsSICTIC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

TYXIT

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.